✦ LIBER ✦

D37 Comparison of the angiotensin II antagonist valsartan with the β-blocker atenolol in patients with severe essential hypertension

✍ Scribed by R. Cifkova; F. Botteri; J. Mann; J. Thirlwell; P. Oddou-Stock

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Isolated systolic hypertension in the ve

✍ P Cicconetti; C.F DiGioacchino; C Deserra; F Thau; D Fidente; M Cacciafesta; V M 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 152 KB

Combination Angiotensin Receptor Blocker

✍ Christina M. Salerno; Laura Demopoulos; Robin Mukherjee; Alan H. Gradman 📂 Article 📅 2004 🏛 Le Jacq Communications, Inc. 🌐 English ⚖ 273 KB

Tolerability profile of tasosartan, a lo

✍ Suzanne Oparil; Alan Gradman; Vasilios Papademetriou; Michael Weber 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 685 KB

Effect of the angiotensin II receptor bl

✍ T. Skurk; Y.-M. Lee; T.-O. Nicuta-Rölfs; B. Haastert; A. Wirth; H. Hauner 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

D29 The efficacy of candesartan; an angi

✍ G.A. MacGregor; T.F. Antonios; F.J. He 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 134 KB

Increased thrombotic and impaired fibrin

✍ Gavriilaki, E; Gkaliagkousi, E; Nikolaidou, B; Triantafyllou, G; Chatzopoulou, F 📂 Article 📅 2014 🏛 Nature Publishing Group 🌐 English ⚖ 315 KB